Yes, kava is legally permitted in China, but its import, sale, and consumption are tightly controlled under the 2021 Narcotics Control Law and 2023 State Food and Drug Administration (SFDA) guidelines.
Kava (Piper methysticum) is not classified as a narcotic in China, yet its psychoactive kavalactones trigger scrutiny under the SFDA’s 2023 “Special Food Additives” framework. Importers must secure pre-market approval from the SFDA, proving kava’s use as a traditional beverage (not a supplement) with no health claims. Unapproved kava products risk confiscation under customs regulations enforced by the General Administration of Customs (GAC). Recent 2026 draft amendments to the Food Safety Law may further restrict kava’s use in functional foods, aligning with China’s broader crackdown on “new psychoactive substances.”
Key Regulations for Kava in China
- SFDA Pre-Market Approval: Kava requires registration as a “new food raw material” (NFRM) under the 2016 NFRM Catalog, mandating toxicology studies and labeling disclaimers. Approval is rare; only a handful of Pacific-origin kava varieties have been tentatively cleared.
- Customs Enforcement: The GAC’s 2024 “Narcotics and Psychotropic Control List” includes kava under Category II surveillance, subjecting shipments to mandatory inspection. Undeclared kava powder or capsules face seizure or fines up to ¥50,000 (~$7,000).
- Provincial Variations: Guangdong and Shanghai customs apply stricter interpretations, often rejecting kava imports even with SFDA approval. Local Market Supervision Bureaus may prosecute unauthorized sales as “illegal food additives” under the 2021 Food Safety Law.